Characterization of Adverse Cutaneous Effects in the Setting of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Retrospective Review

Authors

Rhea Malik, Harvard Medical School
David H. Xiang, Harvard Medical School
Grant J. Riew, Harvard Medical School
Stephanie Sanchez-Melendez, Brigham and Women's Hospital
Shawn Afvari, Brigham and Women's Hospital
Nicole R. LeBoeuf, Brigham and Women's Hospital
Vinod E. Nambudiri, Brigham and Women's Hospital

Author Type(s)

Student

Document Type

Article

Publication Date

10-1-2024

DOI

10.1016/j.jaad.2024.06.037

Journal Title

Journal of the American Academy of Dermatology

Keywords

adnexal tumor, cutaneous effects, enfortumab vedotin, SJS, TEN, urothelial cancer

Disciplines

Medicine and Health Sciences

Recommended Citation

Malik, R., Xiang, D., Riew, G., Sanchez-Melendez, S., Afvari, S., LeBoeuf, N., & Nambudiri, V. (2024). Characterization of Adverse Cutaneous Effects in the Setting of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Retrospective Review. Journal of the American Academy of Dermatology, 91 (4), 753-755. https://doi.org/10.1016/j.jaad.2024.06.037